Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Frank Haims who wrote (1431)	11/16/1998 8:58:00 AM
From: Biomaven	Read Replies (2) of 10280

Frank, Total continence was achieved by around 29% of the high-dose group, vs. around 14% of placebo (p=.057) and 25% for the low-dose group. I'm not sure how these 2-week numbers would compare with a longer trial. In longer trials of oxy, improvement was reported as stable over the trial. Given that in actual practice you compare to base-line (not too many placebos for sale out there) and the total market is reported as 17 million, if these numbers held up it, would mean that around 5 million people could achieve continence by taking this drug. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next